Insulin-Like Growth Factor (IGF) Binding Protein 2 Functions Coordinately with Receptor Protein Tyrosine Phosphatase β and the IGF-I Receptor To Regulate IGF-I-Stimulated Signaling

ABSTRACT Insulin-like growth factor I (IGF-I) is a mitogen for vascular smooth muscle cells (VSMC) and has been implicated in the development and progression of atherosclerosis. IGF binding proteins (IGFBPs) modify IGF-I actions independently of IGF binding, but a receptor-based mechanism by which they function has not been elucidated. We investigated the role of IGFBP-2 and receptor protein tyrosine phosphatase β (RPTPβ) in regulating IGF-I signaling and cellular proliferation. IGFBP-2 bound RPTPβ, which led to its dimerization and inactivation. This enhanced PTEN tyrosine phosphorylation and inhibited PTEN activity. Utilization of substrate trapping and phosphatase-dead mutants showed that RPTPβ bound specifically to PTEN and dephosphorylated it. IGFBP-2 knockdown led to decreased PTEN tyrosine phosphorylation and decreased AKT Ser473 activation. IGFBP-2 enhanced IGF-I-stimulated VSMC migration and proliferation. Analysis of aortas obtained from IGFBP-2−/− mice showed that RPTPβ was activated, and this was associated with inhibition of IGF-I stimulated AKT Ser473 phosphorylation and VSMC proliferation. These changes were rescued following administration of IGFBP-2. These findings present a novel mechanism for coordinate regulation of IGFBP-2 and IGF-I signaling functions that lead to stimulation of VSMC proliferation. The results have important implications for understanding how IGFBPs modulate the cellular response to IGF-I.

[1]  L. Maile,et al.  Insulin‐like growth factor‐binding protein‐2 is required for osteoclast differentiation , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  L. Maile,et al.  Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes , 2012, Diabetologia.

[3]  L. Maile,et al.  Hyperglycemia Enhances IGF-I–Stimulated Src Activation via Increasing Nox4-Derived Reactive Oxygen Species in a PKCζ-Dependent Manner in Vascular Smooth Muscle Cells , 2011, Diabetes.

[4]  Y. Radhakrishnan,et al.  IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells. , 2011, Molecular endocrinology.

[5]  A. Hoffman,et al.  IGFBP-2 enhances VEGF gene promoter activity and consequent promotion of angiogenesis by neuroblastoma cells. , 2011, Endocrinology.

[6]  J. Flanagan,et al.  Proteoglycan-Specific Molecular Switch for RPTPσ Clustering and Neuronal Extension , 2011, Science.

[7]  M. Bouxsein,et al.  The Heparin-binding Domain of IGFBP-2 Has Insulin-like Growth Factor Binding-independent Biologic Activity in the Growing Skeleton* , 2011, The Journal of Biological Chemistry.

[8]  G. Fuller,et al.  JNK mediates insulin-like growth factor binding protein 2/integrin alpha5-dependent glioma cell migration. , 2010, International journal of oncology.

[9]  Y. Radhakrishnan,et al.  Recruitment of Pyk2 to SHPS-1 signaling complex is required for IGF-I-dependent mitogenic signaling in vascular smooth muscle cells , 2010, Cellular and Molecular Life Sciences.

[10]  Federica Cavallo,et al.  Attenuation of PI3K/Akt-Mediated Tumorigenic Signals through PTEN Activation by DNA Vaccine-Induced Anti-ErbB2 Antibodies , 2010, The Journal of Immunology.

[11]  Y. Radhakrishnan,et al.  Insulin-like Growth Factor-I-stimulated Insulin Receptor Substrate-1 Negatively Regulates Src Homology 2 Domain-containing Protein-tyrosine Phosphatase Substrate-1 Function in Vascular Smooth Muscle Cells* , 2010, The Journal of Biological Chemistry.

[12]  Umadevi Veluvolu,et al.  A Monoclonal Antibody Against αVβ3 Integrin Inhibits Development of Atherosclerotic Lesions in Diabetic Pigs , 2010, Science Translational Medicine.

[13]  Jochen Ringe,et al.  Crosstalks between integrin alpha 5 and IGF2/IGFBP2 signalling trigger human bone marrow-derived mesenchymal stromal osteogenic differentiation , 2010, BMC Cell Biology.

[14]  Jimmy Peng,et al.  A role for C. elegans Eph RTK signaling in PTEN regulation. , 2009, Developmental cell.

[15]  Y. Radhakrishnan,et al.  Identification of Novel SHPS-1-associated Proteins and Their Roles in Regulation of Insulin-like Growth Factor-dependent Responses in Vascular Smooth Muscle Cells* , 2009, Molecular & Cellular Proteomics.

[16]  D. Agrawal,et al.  Regulation of cell cycle entry by PTEN in smooth muscle cell proliferation of human coronary artery bypass conduits , 2008, Journal of cellular and molecular medicine.

[17]  D. Agrawal,et al.  Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits , 2008, Journal of cellular and molecular medicine.

[18]  K. Abbott,et al.  Receptor Tyrosine Phosphatase β (RPTPβ) Activity and Signaling Are Attenuated by Glycosylation and Subsequent Cell Surface Galectin-1 Binding* , 2008, Journal of Biological Chemistry.

[19]  D. Clemmons,et al.  p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment. , 2008, Molecular endocrinology.

[20]  M. Bouxsein,et al.  Gender-specific changes in bone turnover and skeletal architecture in igfbp-2-null mice. , 2008, Endocrinology.

[21]  M. Runge,et al.  Leukocyte Antigen-related Deficiency Enhances Insulin-like Growth Factor-1 Signaling in Vascular Smooth Muscle Cells and Promotes Neointima Formation in Response to Vascular Injury* , 2007, Journal of Biological Chemistry.

[22]  D. Clemmons,et al.  The Role of Src Kinase in Insulin-like Growth Factor-dependent Mitogenic Signaling in Vascular Smooth Muscle Cells* , 2006, Journal of Biological Chemistry.

[23]  D. Pei,et al.  Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus , 2006, Neuroscience Letters.

[24]  A. Hoeflich,et al.  Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. , 2005, Endocrinology.

[25]  P. Pérez-Piñera,et al.  Pleiotrophin regulates serine phosphorylation and the cellular distribution of beta-adducin through activation of protein kinase C. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  P. Pérez-Piñera,et al.  Fyn is a downstream target of the pleiotrophin/receptor protein tyrosine phosphatase beta/zeta-signaling pathway: regulation of tyrosine phosphorylation of Fyn by pleiotrophin. , 2005, Biochemical and biophysical research communications.

[27]  L. Maile,et al.  Role of SHPS-1 in the regulation of insulin-like growth factor I-stimulated Shc and mitogen-activated protein kinase activation in vascular smooth muscle cells. , 2005, Molecular biology of the cell.

[28]  P. J. Schlueter,et al.  Targeted knockdown of insulin-like growth factor binding protein-2 disrupts cardiovascular development in zebrafish embryos. , 2005, Molecular endocrinology.

[29]  Seung-Rock Lee,et al.  The major target of the endogenously generated reactive oxygen species in response to insulin stimulation is phosphatase and tensin homolog and not phosphoinositide-3 kinase (PI-3 kinase) in the PI-3 kinase/Akt pathway. , 2004, Molecular biology of the cell.

[30]  M. Elmlinger,et al.  Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. , 2004, Journal of molecular endocrinology.

[31]  Ming Tan,et al.  PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients. , 2004, Cancer cell.

[32]  S. Khosla,et al.  Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. , 2003, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[33]  Yiling Lu,et al.  Src Family Protein-tyrosine Kinases Alter the Function of PTEN to Regulate Phosphatidylinositol 3-Kinase/AKT Cascades* , 2003, Journal of Biological Chemistry.

[34]  R. Baxter,et al.  Cellular actions of the insulin-like growth factor binding proteins. , 2002, Endocrine reviews.

[35]  B. Tönshoff,et al.  Differential effects of insulin-like growth factor binding proteins-1, -2, -3, and -6 on cultured growth plate chondrocytes. , 2002, Kidney international.

[36]  J. Fagin,et al.  Targeted Expression of a Protease-resistant IGFBP-4 Mutant in Smooth Muscle of Transgenic Mice Results in IGFBP-4 Stabilization and Smooth Muscle Hypotrophy* , 2002, The Journal of Biological Chemistry.

[37]  Nan Zhang,et al.  Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. , 2002, Archives of biochemistry and biophysics.

[38]  A. Hoeflich,et al.  Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter? , 2001, Cancer research.

[39]  J. Craft,et al.  Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head andeck, despite loss of heterozygosity at this locus , 2001, British Journal of Cancer.

[40]  A. Hoeflich,et al.  Printed in U.S.A. Copyright © 2001 by The Endocrine Society Growth Inhibition in Giant Growth Hormone Transgenic Mice by Overexpression of Insulin-Like Growth Factor- Binding Protein-2 , 2000 .

[41]  D. Clemmons,et al.  Substitutions for Hydrophobic Amino Acids in the N-terminal Domains of IGFBP-3 and -5 Markedly Reduce IGF-I Binding and Alter Their Biologic Actions* , 2000, The Journal of Biological Chemistry.

[42]  M. Noda,et al.  Pleiotrophin signals increased tyrosine phosphorylation of β-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase β/ζ , 2000 .

[43]  T. Nam,et al.  Thrombospondin and osteopontin bind to insulin-like growth factor (IGF)-binding protein-5 leading to an alteration in IGF-I-stimulated cell growth. , 2000, Endocrinology.

[44]  M. Noda,et al.  Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Jun Ding,et al.  Insulin-like growth factor binding protein 2 is a growth inhibitory protein conserved in zebrafish. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[46]  M. Noda,et al.  Involvement of Receptor-like Protein Tyrosine Phosphatase ζ/RPTPβ and Its Ligand Pleiotrophin/Heparin-binding Growth-associated Molecule (HB-GAM) in Neuronal Migration , 1998, The Journal of cell biology.

[47]  G. Werther,et al.  Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. , 1997, Endocrinology.

[48]  A. Toker,et al.  Signalling through the lipid products of phosphoinositide-3-OH kinase , 1997, Nature.

[49]  J. Noel,et al.  Structural basis for inhibition of receptor protein-tyrosine phosphatase-α by dimerization , 1996, Nature.

[50]  D. Clemmons,et al.  Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Noel,et al.  Structural basis for inhibition of receptor protein-tyrosine phosphatase-alpha by dimerization. , 1996, Nature.

[52]  D. Clemmons,et al.  Properties of an insulin-like growth factor-binding protein-4 protease that is secreted by smooth muscle cells. , 1995, Endocrinology.

[53]  D. Clemmons,et al.  Insulin-like growth factors and their binding proteins: biological actions. , 1995, Endocrine reviews.

[54]  K. Shitara,et al.  Brain-specific receptor-type protein-tyrosine phosphatase RPTP beta is a chondroitin sulfate proteoglycan in vivo. , 1994, The Journal of biological chemistry.

[55]  D. Clemmons,et al.  Cloning and sequence determination of bovine insulin‐like growth factor binding protein‐2 (IGFBP‐2): Comparison of its structral and functional properties with IGFBP‐1 , 1992, Journal of cellular biochemistry.

[56]  D. Clemmons,et al.  Regulation of insulin-like growth factor binding protein synthesis and secretion in a bovine epithelial cell line. , 1991, Endocrinology.